Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1
  2. Zhang, M. Y.; Borges, A. R.; Ptak, R. G.; Wang, Y. P.; Dimitrov, A. S.; Alam, S. M.; Wieczorek, L.; Bouma, P.; Fouts, T.; Jiang, S. B.; Polonis, V. R.; Haynes, B. F.; Quinnan, G. V.; Montefiori, D. C.; Dimitrov, D. S.
  3. Mabs. 2010, May-Jun; 2(3): 266-274.
  1. 2.   Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-I
  2. Giomarelli, B.; Washington, V. A.; Chisholm, M. M.; Quigley, L.; McMahon, J. B.; Mori, T.; McVicar, D. W.
  3. Thrombosis and Haemostasis. 2007, Jun; 97(6): 955-964.
  1. 3.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 4.   Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. British Journal of Haematology. 2005, MAR; 128(5): 602-609.
  1. 5.   A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22(+) tumor cells
  2. Arndt, M. A. E.; Krauss, J.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. Journal of Immunotherapy. 2005, MAY-JUN; 28(3): 245-251.
  1. 6.   Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers
  2. Arndt, M. A. E.; Krauss, R.; Rybak, S. M.
  3. Febs Letters. 2004, DEC 17; 578(3): 257-261.
  1. 7.   Impact of antibody framework residue V-H-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Zhu, Z.; Newton, D. L.; Vu, B. K.; Choudhry, V.; Darbha, R.; Ji, X.; Courtenay-Luck, N. S.; Deonarain, M. P.; Richards, J.; Rybak, S. M.
  3. British Journal of Cancer. 2004 90(9): 1863-1870.
  1. 8.   Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
  2. Zhang, M. Y.; Shu, Y. U.; Rudolph, D.; Prabakaran, P.; Labrijn, A. F.; Zwick, M. B.; Lal, R. B.; Dimitrov, D. S.
  3. Journal of Molecular Biology. 2004 335(1): 209-219.
  1. 9.   Generation of a highly stable, internalizing anti-CD22 single- chain Fv fragment for targeting non-Hodgkin's lymphoma
  2. Arndt, M. A. E.; Krauss, J.; Schwarzenbacher, R.; Vu, B. K.; Greene, S.; Rybak, S. M.
  3. International Journal of Cancer. 2003 107(5): 822-829.
  1. 10.   Diverting a protein from its cellular location by intracellular antibodies - The case of p21Ras
  2. Lener, M.; Horn, I. R.; Cardinale, A.; Messina, S.; Nielsen, U. B.; Rybak, S. M.; Hoogenboom, H. R.; Cattaneo, A.; Biocca, S.
  3. European Journal of Biochemistry. 2000 267(4): 1196-1205.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel